These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15639191)

  • 21. A homology model for human alpha-l-iduronidase: insights into human disease.
    Rempel BP; Clarke LA; Withers SG
    Mol Genet Metab; 2005 May; 85(1):28-37. PubMed ID: 15862278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.
    Baldo G; Quoos Mayer F; Burin M; Carrillo-Farga J; Matte U; Giugliani R
    Cells Tissues Organs; 2012; 195(4):323-9. PubMed ID: 21778683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nonpathologic allele (IW) for low alpha-L-iduronidase enzyme activity vis-a-vis prenatal diagnosis of Hurler syndrome.
    Whitley CB; Gorlin RJ; Krivit W
    Am J Med Genet; 1987 Sep; 28(1):233-43. PubMed ID: 3118714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfate.
    Muller VJ; Hopwood JJ
    Clin Genet; 1984 Nov; 26(5):414-21. PubMed ID: 6437709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I.
    Kakkis E; McEntee M; Vogler C; Le S; Levy B; Belichenko P; Mobley W; Dickson P; Hanson S; Passage M
    Mol Genet Metab; 2004; 83(1-2):163-74. PubMed ID: 15464431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development.
    Baxter MA; Wynn RF; Schyma L; Holmes DK; Wraith JE; Fairbairn LJ; Bellantuono I
    J Inherit Metab Dis; 2005; 28(6):1045-53. PubMed ID: 16435198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice.
    Watson G; Bastacky J; Belichenko P; Buddhikot M; Jungles S; Vellard M; Mobley WC; Kakkis E
    Gene Ther; 2006 Jun; 13(11):917-25. PubMed ID: 16482204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucopolysaccharidosis type I: clinical and biochemical study.
    Bassyouni HT; Afifi HH; el-Awadi MK; Meguid NA
    East Mediterr Health J; 2000; 6(2-3):359-66. PubMed ID: 11556024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients.
    Ashton LJ; Brooks DA; McCourt PA; Muller VJ; Clements PR; Hopwood JJ
    Am J Hum Genet; 1992 Apr; 50(4):787-94. PubMed ID: 1550122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human alpha-L-iduronidase. Catalytic properties and an integrated role in the lysosomal degradation of heparan sulphate.
    Freeman C; Hopwood JJ
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):899-908. PubMed ID: 1554373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical spectrum of alpha-L-iduronidase deficiency.
    Roubicek M; Gehler J; Spranger J
    Am J Med Genet; 1985 Mar; 20(3):471-81. PubMed ID: 3922223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).
    Wraith JE; Beck M; Lane R; van der Ploeg A; Shapiro E; Xue Y; Kakkis ED; Guffon N
    Pediatrics; 2007 Jul; 120(1):e37-46. PubMed ID: 17606547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies.
    Bunge S; Clements PR; Byers S; Kleijer WJ; Brooks DA; Hopwood JJ
    Biochim Biophys Acta; 1998 Sep; 1407(3):249-56. PubMed ID: 9748610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.
    Unger EG; Durrant J; Anson DS; Hopwood JJ
    Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):43-9. PubMed ID: 7998955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotype prediction for mucopolysaccharidosis type I by in silico analysis.
    Ou L; Przybilla MJ; Whitley CB
    Orphanet J Rare Dis; 2017 Jul; 12(1):125. PubMed ID: 28676128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years.
    Sifuentes M; Doroshow R; Hoft R; Mason G; Walot I; Diament M; Okazaki S; Huff K; Cox GF; Swiedler SJ; Kakkis ED
    Mol Genet Metab; 2007 Feb; 90(2):171-80. PubMed ID: 17011223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme replacement therapy in feline mucopolysaccharidosis I.
    Kakkis ED; Schuchman E; He X; Wan Q; Kania S; Wiemelt S; Hasson CW; O'Malley T; Weil MA; Aguirre GA; Brown DE; Haskins ME
    Mol Genet Metab; 2001 Mar; 72(3):199-208. PubMed ID: 11243725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dried blood spot analysis: an easy and reliable tool to monitor the biochemical effect of hematopoietic stem cell transplantation in hurler syndrome patients.
    Aldenhoven M; de Koning TJ; Verheijen FW; Prinsen BH; Wijburg FA; van der Ploeg AT; de Sain-van der Velden MG; Boelens J
    Biol Blood Marrow Transplant; 2010 May; 16(5):701-4. PubMed ID: 20096360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mucopolysaccharidosis type I in the Cuban population].
    Menéndez-Sainz C; Zaldívar-Muñoz C; González-Quevedo A
    Rev Neurol; 2003 Sep 16-30; 37(6):525-8. PubMed ID: 14533069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I.
    Brooks DA
    Expert Opin Biol Ther; 2002 Dec; 2(8):967-76. PubMed ID: 12517274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.